Nabriva Therapeutics plc Lessee, Operating Lease, Liability, to be Paid
Nabriva Therapeutics plc had Lessee, Operating Lease, Liability, to be Paid of $498.00 thousand as of 2023-03-31, per its 10-Q filed 2023-05-22.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2023-05-22
- 2023-03-31: Lessee, Operating Lease, Liability, to be Paid $498.00K.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid $892.00K.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid $785.00K.
- 2020-12-31: Lessee, Operating Lease, Liability, to be Paid $171.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2023-03-31 | $498.00K 10-Q · filed 2023-05-22 |
| 2022-12-31 | $892.00K 10-K · filed 2023-04-17 |
| 2021-12-31 | $785.00K 10-K · filed 2022-03-29 |
| 2020-12-31 | $171.00K 10-K · filed 2021-03-11 |
| 2020-09-30 | $1.67M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.82M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.95M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $2.08M 10-K · filed 2020-03-12 |
| 2019-09-30 | $2.20M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.33M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $2.48M 10-Q · filed 2019-05-10 |